Mental Health

This movement has aimed to address the mental health care epidemic in the United States.

Reducing stigma, improving mental health benefits, and addressing workload concerns all need to happen simultaneously.

Schizophrenia is a chronic mental illness that significantly affects patients through its symptoms, associated health conditions, and treatment challenges, with long-acting injectable antipsychotics offering potential benefits in improving adherence and reducing relapses.

Expert shares insights on leadership resilience, emphasizing self-awareness, team development, and maintaining personal worth beyond professional achievements.

Expert explores the critical importance of emotional intelligence, work-life balance, and strategic leadership in pharmacy.

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

Expert offers insights into managing stress and preventing burnout in pharmacy leadership

Long-acting injectables offer a promising approach to schizophrenia treatment, but their effective use requires careful management and patient education.

Michael McGuire, PharmD, highlights the importance of early intervention in hospital settings, leveraging manufacturer programs, and navigating complex dosing regimens.

The move is expected to expand clozapine access for patients with schizophrenia.

LAIs offer a variety of benefits, from improved medication adherence and relapse prevention to enhanced quality of life for individuals with schizophrenia.

Research has demonstrated a reduction in hospitalization risk associated with the use of LAIs, but some barriers can prevent the wider adoption of this approach.

The authors suggest future research should consider inflammation and the gut as potential therapeutic targets improve depression in patients with chronic kidney disease (CKD).

Pharmacists can provide resources, monitor medications, and extend compassionate support to patients experiencing mental health challenge.

Vietnam war trauma continues to affect veterans’ health 50 years later.

In the phase 3 CONNEX clinical trial program, iclepertin did not meet its primary and secondary end points.

The demands of the pharmacy profession—long hours, high stress, and emotional strain—can take a toll on pharmacists’ well-being.

Pregnant individuals with multiple sclerosis (MS) are more likely to experience mental illness both during their pregnancy and in the first years after giving birth.

Despite these findings, navacaprant was generally well-tolerated and safe in patients with major depressive disorder.

The study found that internalizing and externalizing factors, brain maturation, and decreasing volumes of brain regions were linked to eating disorders.

Esketamine targets glutamate, the most abundant neurotransmitters in the brain.

The authors note that future research will observe personality changes when psilocybin is used in patients with opioid-use disorder.

Posttraumatic stress disorder is found to be associated with coronary artery disease, hypertension, and heart failure.

The rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.

COVID-19 survivors deemed the most highly impacted and fearful also reported the lowest health-related quality of life scores, indicating an association.